Wegovy Weight Loss Injection UK Private Prescription £79.00

Clinically Proven UK Registered Pharmacy

Weight Loss Injection Wegovy UK - Private Prescription

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £10 off for new customers
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£89.00 From £79.00 £10 discount using discount code Weightlossnew
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £135.00

£36.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £169.00

£44.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £210.00

£55.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £235.00

£61.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £260.00

£67.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £277.00

£71.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £79.00

£22.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £99.00

£27.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £109.00

£29.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £159.00

£42.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £189.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation

Seeking a wegovy weight loss injection uk private prescription with transparent pricing and expert clinical support? Cured Pharmacy offers genuine UK-licensed Wegovy from £79.00, with free online consultations completed in under 3 minutes by our UK-registered clinical team. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every prescription meets MHRA standards for safety and efficacy.

How Wegovy Semaglutide Injections Work for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics natural hormones your body produces after eating [1]. By activating GLP-1 receptors in the brain, pancreas, and digestive system, semaglutide reduces appetite, slows gastric emptying, and improves blood sugar regulation — creating the metabolic conditions that support sustainable weight reduction.

In the landmark STEP 1 clinical trial, participants using Wegovy alongside lifestyle modifications achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [1]. These results led to MHRA approval in 2021 and subsequent NICE guidance recommending semaglutide for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity [2].

Unlike oral appetite suppressants, Wegovy's once-weekly subcutaneous injection delivers consistent therapeutic levels throughout the week. The gradual dose escalation protocol — starting at 0.25mg and increasing to a maintenance dose of 2.4mg over 16-20 weeks — minimises gastrointestinal side effects whilst optimising weight loss outcomes [3].

Wegovy Injection UK Price and What's Included

Every Wegovy prescription at Cured Pharmacy includes a comprehensive clinical assessment by a UK-registered prescriber. Your clinician reviews your medical history, current medications, BMI calculation, and weight loss goals to determine whether Wegovy is clinically appropriate and which dosing schedule suits your individual needs.

Our GPhC-registered pharmacy (9012511) dispenses only genuine UK-licensed Wegovy manufactured by Novo Nordisk. Each pen arrives in original packaging with patient information leaflets, stored and transported under temperature-controlled conditions to maintain medication integrity. We use 100% discreet packaging — no pharmacy branding or treatment details visible on the outer parcel.

Transparent Pricing Before Your Consultation

At Cured Pharmacy, you see the exact price before completing your free clinical assessment. Our wegovy weight loss injection uk private prescription service starts from £79.00, with no hidden consultation fees or surprise charges at checkout. This price includes your UK prescriber review, genuine MHRA-licensed Wegovy pen, and discreet home delivery.

We guarantee the lowest prices in the UK. If you find a lower advertised price from another registered UK pharmacy for the same Wegovy dose, we'll match it. Our transparent pricing model means you can budget confidently for your weight management programme without navigating complex tiered pricing structures or membership schemes.

Who Can Use Wegovy Weight Loss Injections

Clinical trials excluded patients under 18 years, so Wegovy is licensed only for adult use in the UK. If you have a history of pancreatitis, diabetic retinopathy, or renal impairment, your prescriber will carefully evaluate the risk-benefit profile before recommending treatment.

Successful weight loss with Wegovy requires commitment to lifestyle modifications alongside medication. The STEP trials combined semaglutide with reduced-calorie diet and increased physical activity, demonstrating that pharmacotherapy works best as part of a comprehensive weight management programme [1]. Your prescriber may recommend nutritional counselling or structured exercise plans to optimise your outcomes.

Clinical Eligibility Criteria

NICE guidelines recommend semaglutide 2.4mg for adults with an initial BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease [2]. Your UK prescriber will calculate your BMI during the online consultation and assess your medical suitability.

Wegovy is not suitable during pregnancy or breastfeeding, for patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, or those with severe gastrointestinal disease [3]. Your clinical assessment will identify any contraindications before a prescription is issued.

Treatment Active Ingredient Injection Frequency Starting Price
Wegovy Semaglutide 2.4mg Once weekly From £89.00
Saxenda Liraglutide 3mg Once daily From £68.00
Mounjaro Tirzepatide Once weekly From £145.00

Wegovy Dosing Schedule and Administration

Wegovy follows a structured dose escalation protocol designed to improve gastrointestinal tolerability whilst reaching the therapeutic 2.4mg maintenance dose. You begin with 0.25mg once weekly for four weeks, then increase to 0.5mg for four weeks, 1mg for four weeks, 1.7mg for four weeks, and finally 2.4mg as your ongoing maintenance dose [3].

Each pre-filled pen delivers a single subcutaneous injection into your abdomen, thigh, or upper arm. You choose the same day each week for your injection — many patients find Sunday evenings convenient to establish a consistent routine. The pen design requires no dose measurement or needle attachment, making self-administration straightforward even for injection-naïve patients.

If you miss a dose and it's been less than five days, inject as soon as you remember. If more than five days have passed, skip that dose and resume your regular schedule. Never double up doses to compensate for missed injections. If you experience persistent nausea or vomiting that prevents you from tolerating dose increases, your prescriber may extend the time at your current dose before escalating further [3].

Expected Results and Clinical Outcomes with Wegovy

Beyond the number on the scale, clinical trials demonstrated improvements in cardiometabolic risk factors including reductions in waist circumference, blood pressure, HbA1c in patients with prediabetes, and inflammatory markers [1]. Many patients report enhanced mobility, reduced joint pain, improved sleep quality, and better psychological wellbeing as weight decreases.

Wegovy is intended for chronic weight management, not short-term use. Discontinuing treatment often leads to weight regain, as observed in STEP 4 where participants who switched from semaglutide to placebo regained approximately two-thirds of their lost weight over 48 weeks [4]. Your prescriber will discuss long-term treatment strategies and how to maintain results if you eventually discontinue Wegovy.

Timeline for Weight Loss

Most patients notice reduced appetite and early weight loss within the first 4-8 weeks of starting Wegovy, even at the lower initial doses. However, maximal weight reduction typically occurs after reaching the 2.4mg maintenance dose and continuing treatment for several months. In STEP 1, participants achieved approximately 5% weight loss by week 20, 10% by week 40, and peak reductions around week 60-68 [1].

Individual results vary based on baseline BMI, adherence to lifestyle modifications, metabolic factors, and concurrent medications. Your prescriber will monitor your progress and may recommend continuing treatment if you achieve at least 5% weight loss after 12 weeks at the maintenance dose, in line with NICE guidance [2].

Wegovy Side Effects and Safety Considerations

In animal studies, semaglutide caused thyroid C-cell tumours at exposures similar to human therapeutic doses, though no cases of medullary thyroid carcinoma have been confirmed in human trials [3]. As a precaution, Wegovy is contraindicated in patients with personal or family history of this rare cancer type.

Your prescriber will review your complete medication list during consultation, as Wegovy can delay gastric emptying and potentially affect absorption of oral medications. If you take oral contraceptives, levothyroxine, or medications with narrow therapeutic windows, your clinician may recommend specific timing strategies to maintain therapeutic efficacy [3].

Common and Serious Adverse Effects

The most frequently reported side effects are gastrointestinal: nausea (44% of participants in STEP 1), diarrhoea (30%), vomiting (24%), constipation (24%), and abdominal pain (20%) [1]. These effects are typically mild to moderate, most common during dose escalation, and diminish over time as your body adapts to semaglutide. Eating smaller portions, avoiding high-fat meals, and staying well-hydrated can help manage these symptoms.

Serious but rare adverse events include pancreatitis, gallbladder disease, acute kidney injury (usually secondary to dehydration from vomiting/diarrhoea), and hypoglycaemia when used with insulin or sulfonylureas [3]. Contact your GP or NHS 111 immediately if you experience severe persistent abdominal pain, signs of pancreatitis, or symptoms of dehydration.

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
  2. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. https://www.nice.org.uk/guidance/ta875
  3. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799
  4. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary. Weight loss outcomes depend on multiple factors including adherence to lifestyle modifications, baseline BMI, and individual metabolic response.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How much does a Wegovy weight loss injection UK private prescription cost?
Wegovy starts from £79.00 at Cured Pharmacy, including your UK prescriber consultation, genuine MHRA-licensed medication, and discreet home delivery with no hidden fees.
Can I buy Wegovy online without seeing a doctor?
No. Wegovy is a prescription-only medication in the UK and legally requires a clinical assessment by a UK-registered prescriber before it can be dispensed, even when purchasing online.
How long does it take to lose weight on Wegovy injections?
Most patients notice initial weight loss within 4-8 weeks, with peak reductions typically occurring after 60-68 weeks at the 2.4mg maintenance dose. In clinical trials, average weight loss was 14.9% of initial body weight.
Is Wegovy better than Saxenda for weight loss?
Clinical trials suggest Wegovy (semaglutide 2.4mg once weekly) produces greater average weight loss than Saxenda (liraglutide 3mg daily), though individual responses vary. Your UK prescriber will recommend the most appropriate treatment based on your medical history and preferences.
What happens if I miss a Wegovy injection?
If less than five days have passed, inject as soon as you remember. If more than five days, skip that dose and resume your regular weekly schedule — never double up doses.
Can I get Wegovy on the NHS or do I need a private prescription?
Wegovy is available through the NHS in limited circumstances via specialist weight management services, though access varies by region and waiting times can be extensive. A private prescription offers immediate access subject to clinical suitability.
How do I inject Wegovy at home?
Wegovy comes in a pre-filled pen that you inject once weekly under the skin of your abdomen, thigh, or upper arm. Your medication arrives with detailed instructions, and our clinical team can provide administration guidance during your consultation.
Will I regain weight after stopping Wegovy?
Clinical data shows that discontinuing Wegovy often leads to weight regain, with participants in STEP 4 regaining approximately two-thirds of lost weight within 48 weeks of stopping treatment. Long-term weight management strategies are important to discuss with your prescriber.